XML 40 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
AXT, Inc. Stockholders' Equity
Noncontrolling Interests
Total
Balance, beginning of period at Dec. 31, 2019 $ 3,532 $ 41 $ 236,957 $ (47,783) $ (4,862) $ 187,885 $ 4,877 $ 192,762
Balance (in shares) at Dec. 31, 2019 883 40,632            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock options exercised   $ 1 2,535     2,536   2,536
Common stock options exercised (in shares)   905            
Sale of subsidiary shares to noncontrolling interests     396     396   396
Restricted stock awards canceled   (13)            
Stock-based compensation     2,623     2,623   2,623
Issuance of common stock in the form of restricted stock (in shares)   443            
Purchase of subsidiary shares from noncontrolling interests     (1,398)     (1,398) (202) (1,600)
Adjustment to noncontrolling interests in connection with the reorganization and alignment of assets under Tongmei     (10,732)     (10,732) 10,732  
Net dividend declared by joint ventures             (2,238) (2,238)
Net income       3,238   3,238 1,803 5,041
Other comprehensive income (loss)         8,071 8,071 378 8,449
Balance, end of period at Dec. 31, 2020 $ 3,532 $ 42 230,381 (44,545) 3,209 192,619 15,350 207,969
Balance (in shares) at Dec. 31, 2020 883 41,967            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock options exercised   $ 1 1,669     1,670   1,670
Common stock options exercised (in shares)   507            
Sale of subsidiary shares to noncontrolling interests     (262)     (262) 1,413 1,151
Transfer of subsidiary with noncontrolling interests     (1,229)     (1,229) 1,229  
Investment in subsidiary with redeemable noncontrolling interest               (132)
Restricted stock awards canceled   (14)            
Stock-based compensation     4,519     4,519   4,519
Issuance of common stock in the form of restricted stock (in shares)   426            
Purchase of subsidiary shares from noncontrolling interests     (2,691)     (2,691) (1,039) (3,730)
Transfer of subsidiary with redeemable noncontrolling interest     (1,241)     (1,241)   (1,241)
Noncontrolling interest portion of Tongmei stock-based compensation     (62)     (62) 40 (22)
Sale of common stock to employees in connection with the reorganization     538     538   538
Adjustment to noncontrolling interests in connection with the reorganization and alignment of assets under Tongmei               (1,229)
Net income       14,575   14,575 1,045 15,620
Other comprehensive income (loss)         3,093 3,093 279 3,372
Balance, end of period at Dec. 31, 2021 $ 3,532 $ 43 231,622 (29,970) 6,302 211,529 18,317 229,846
Balance (in shares) at Dec. 31, 2021 883 42,886            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock options exercised   $ 1 517     518   518
Common stock options exercised (in shares)   172            
Tongmei stock-based compensation     733     733   733
Investment in subsidiary from noncontrolling interest             1,887 1,887
Investment in subsidiary with redeemable noncontrolling interest     (471)     (471)   (471)
Restricted stock awards canceled   (91)            
Stock-based compensation     3,273     3,273   3,273
Issuance of common stock in the form of restricted stock (in shares)   587            
Purchase of subsidiary shares from noncontrolling interests     (466)     (466) 2,699 2,233
Noncontrolling interest portion of Tongmei stock-based compensation     100     100 (42) 58
Net income       15,811   15,811 1,333 17,144
Other comprehensive income (loss)         (9,420) (9,420) (901) (10,321)
Balance, end of period at Dec. 31, 2022 $ 3,532 $ 44 $ 235,308 $ (14,159) $ (3,118) $ 221,607 $ 23,293 $ 244,900
Balance (in shares) at Dec. 31, 2022 883 43,554